Clinical Trial Update: Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer [Phase 2]

View source ↗

Summary

Phase II neoadjuvant trial in breast cancer evaluating weekly nab-paclitaxel (Abraxane) with carboplatin and bevacizumab; the study (NCT00675259) has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-24